u/Nelsons93

I see a lot of people just dumping everything into the S&P 500 or US tech right now but I wanted to go a different direction. I just finalized this new pie and wanted to get some opinions from you guys. I named it the Global Passport. I have got the Invesco All World in there as a base at 12.5% but I actively decided to lean heavier into markets like India and Taiwan which are also at 12.5% each. I also allocated a good chunk to Japan and Korea at 10% each and then spread the rest across places like Mexico, Saudi Arabia, Vietnam, Australia, Brazil, Turkey and Indonesia. I am trying to let compounding do the work over the long run without being completely reliant on big tech and the US market. What do you guys think of this setup? Let me know if I am missing any obvious blind spots or if I am overcomplicating it.

Being a Genprex investor right now feels exactly like being 5-0 down in the 89th minute of a cup final.

Rain pouring.
Fans leaving the stadium.
Manager looks finished. 😂

We are all exhausted, battered, and questioning every life decision.

But today is Wednesday May 13th, and we finally get the GPX-002 diabetes data at ASGCT.

I’m not saying it moves. I’m not saying miracles happen.

But this is one of the few real things we’ve had to watch in a while.

I’m still holding the line.

Who’s standing with me?

Drop your wildest predictions below 👀

NFA

#ASGCT2026 #GeneTherapy #Diabetes #Biotech $GNPX

$GNPX
The chart looks ugly, the sentiment is dead, and nobody cares.
That’s exactly why I’m still watching.
Biotech turns when you least expect it.

Heading into power hour and the $SST borrow fee is still stubbornly sitting at 672% (hit a max of 681% earlier today). Fintel is showing only 4k shares left to borrow. The cost to hold these short positions overnight is going to be brutal. Really curious to see how the daily candle closes here.